Twist Bioscience (TWST) Revenue (2017 - 2026)

Twist Bioscience (TWST) has reported Revenue for 10 consecutive years, with $118.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 23.24% year-over-year to $118.4 million in Q2 2026; TTM through Jun 2026 was $431.8 million, a 19.19% increase from a year earlier, with the FY2025 full-year figure at $376.6 million, up 20.32% from the prior year.
• Revenue was $118.4 million for Q2 2026 at Twist Bioscience, up from $110.7 million in the prior quarter.
• Over five years, Revenue peaked at $118.4 million in Q2 2026 and troughed at $48.1 million in Q1 2022.
• A 5-year average of $79.4 million and a median of $78.4 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 60.24% in 2022 and gained 13.59% in 2023, its largest moves.
• Over 5 years, Revenue stood at $54.2 million in 2022, then jumped by 31.81% to $71.5 million in 2023, then advanced by 24.08% to $88.7 million in 2024, then grew by 16.89% to $103.7 million in 2025, then gained by 14.15% to $118.4 million in 2026.
• The last three Revenue figures came in at $118.4 million (Q2 2026), $110.7 million (Q1 2026), and $103.7 million (Q4 2025), per Business Quant data.